Bromazolam (XLI-268) is a triazolobenzodiazepine (TBZD) which was first synthesised in 1976, but was never marketed. [2] . It has subsequently been sold as a designer drug, first being definitively identified by the EMCDDA in Sweden in 2016. [3] .

Dec 4, 2023 · — The Hamilton County Coroner is warning about a dangerous new emerging drug called Bromazolam. Bromazolam, the coroner said, is what is known as a designer benzodiazepine and is similar to...

1 day ago · The most recent bust of Bromazolam in New York City was in February. "One really significant seizure in Long Island City, where this is 3.4 million fake pills," Tarentino said.

Jan 4, 2024 · Bromazolam is a “designer” triazolobenzodiazepine synthesized in 1976 but never approved for therapeutic use (1). Since its first detection in Sweden in 2016, a significant increase has persisted in both the toxicologic identification of bromazolam in combination with fentanyl and its identification in counterfeit benzodiazepine preparations (2).

Jan 17, 2024 · Bromazolam is a new psychoactive substance (NPS) benzodiazepines, popularly known as designer benzodiazepines. Here’s what we know about its safety and effects. Responsible Use

Mar 19, 2024 · Bromazolam, a benzodiazepine derivative, poses a significant threat in Florida’s substance abuse landscape due to its composition and the alarming rise in overdoses. Its insidious nature jeopardizes physical and mental well-being.

Bromazolam is a triazolo-benzodiazepine structurally related to the internationally controlled substance alprazolam in which the chlorine atom is replaced by a bromine atom. Bromazolam

Jan 9, 2024 · Bromazolam, a street drug that has been detected with increasing frequency in the United States, has reportedly caused protracted seizures, myocardial injury, comas, and multiday intensive care...

Bromazolam has been identified in more than 190 toxicology samples tested at the Center for Forensic Science Research and Education (CFSRE), displaying an increase in positivity from 1% in Q1 2021 to 13% in Q2 2022.

Bromazolam is a type of triazolo-benzodiazepine that scientists originally developed in the 1970s. It has never been approved for medical use in the U.S. or in any other country.